Journal of the National Cancer Institute Advance Access originally published online on June 17, 2009
JNCI Journal of the National Cancer Institute 2009 101(13):902-903; doi:10.1093/jnci/djp163
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press.
EDITORIALS |
Are We Getting Closer to Molecular Population Screening for Colorectal Cancer?
Affiliations of author: Clalit National Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel
Correspondence to: Gad Rennert, MD, PhD, Clalit National Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center, 7 Michal St, Haifa 34362, Israel (e-mail: rennert@tx.technion.ac.il).
| The first 10% of the full text of this article appears below. |
The best methods to bring about a reduction in the incidence and mortality of colorectal cancer in the world have been the subject of much debate in recent years. Colorectal cancer is highly preventable through behavioral changes in diet and physical activity; still, much effort has been invested in developing efficient screening technologies for secondary prevention.
Public health theory stresses a number of requirements that must be met before screening for a disease can be initiated (1). This line of thought differs from the usual clinical situation in which symptomatic patients present themselves to the health system in search of medical help. The screening setting refers to very large populations
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2009 101: 901.
J Natl Cancer Inst 2009 101: 901.